266 related articles for article (PubMed ID: 35461955)
1. Low rates of HPV vaccination and cervical cancer screening: Challenges and opportunities in the context of the COVID-19 pandemic.
Smith DL; Perkins RB
Prev Med; 2022 Jun; 159():107070. PubMed ID: 35461955
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
3. HPV Update: Vaccination, Screening, and Associated Disease.
McNamara M; Batur P; Walsh JME; Johnson KM
J Gen Intern Med; 2016 Nov; 31(11):1360-1366. PubMed ID: 27184752
[TBL] [Abstract][Full Text] [Related]
4. Towards cervical cancer eradication: joint force of HPV vaccination and HPV-based cervical cancer screening.
Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):806-7. PubMed ID: 26068650
[No Abstract] [Full Text] [Related]
5. [Screening for cervical cancer, human papillomavirus (HPV) vaccination].
Schaff Z; Járay B
Magy Onkol; 2022 Dec; 66(4):325-330. PubMed ID: 37161827
[TBL] [Abstract][Full Text] [Related]
6. Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
Poljak M; Cuschieri K; Waheed DE; Baay M; Vorsters A
Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):21-26. PubMed ID: 33765753
[TBL] [Abstract][Full Text] [Related]
7. HPV Vaccination and Cervical Cancer Screening Policies and Practices in 18 Countries, Territories and Entities across Eastern Europe and Central Asia.
Davies P; Aluloski I; Arifdjanova D; Brcanski J; Davidzenka A; Durdyeva A; Gayrat Umarzoda S; Goshliyev K; Jovanovic V; Jugeli L; Kocinaj-Berisha M; Maistruk G; Naumovic T; Pilav A; Rzayeva G; Saribekyan K; Siljak S; Ten E; Valuta D; Veljkovic M; Yildirimkaya G; Ylli A; Zhylkaidarova A; Melnic E
Asian Pac J Cancer Prev; 2023 May; 24(5):1781-1788. PubMed ID: 37247301
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic.
Elfström M; Gray PG; Dillner J
Elife; 2023 Dec; 12():. PubMed ID: 38085566
[TBL] [Abstract][Full Text] [Related]
9. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
Franco EL;
Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
[No Abstract] [Full Text] [Related]
10. Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.
Ferrara P; Dallagiacoma G; Alberti F; Gentile L; Bertuccio P; Odone A
Prev Med; 2022 Nov; 164():107264. PubMed ID: 36150446
[TBL] [Abstract][Full Text] [Related]
11. Impact of COVID-19 on cervical cancer screening: Challenges and opportunities to improving resilience and reduce disparities.
Wentzensen N; Clarke MA; Perkins RB
Prev Med; 2021 Oct; 151():106596. PubMed ID: 34217415
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
13. HPV vaccination and cervical cancer screening.
Bewley S
Lancet; 2022 May; 399(10339):1939. PubMed ID: 35598621
[No Abstract] [Full Text] [Related]
14. HPV vaccination and cervical cancer screening.
Kamamoto S; Murayama A; Hamaki T; Kusumi E; Kami M
Lancet; 2022 May; 399(10339):1939-1940. PubMed ID: 35598620
[No Abstract] [Full Text] [Related]
15. The European response to the WHO call to eliminate cervical cancer as a public health problem.
Arbyn M; Gultekin M; Morice P; Nieminen P; Cruickshank M; Poortmans P; Kelly D; Poljak M; Bergeron C; Ritchie D; Schmidt D; Kyrgiou M; Van den Bruel A; Bruni L; Basu P; Bray F; Weiderpass E
Int J Cancer; 2021 Jan; 148(2):277-284. PubMed ID: 32638362
[TBL] [Abstract][Full Text] [Related]
16. HPV prevention and control - The way forward.
Vorsters A; Bosch FX; Poljak M; Waheed DE; Stanley M; Garland SM;
Prev Med; 2022 Mar; 156():106960. PubMed ID: 35065979
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
18. HPV vaccination and cervical cancer screening - Authors' reply.
Sasieni P; Castanon A
Lancet; 2022 May; 399(10339):1940. PubMed ID: 35598622
[No Abstract] [Full Text] [Related]
19. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
20. HPV testing and vaccination in Europe.
Leeson SC; Alibegashvili T; Arbyn M; Bergeron C; Carriero C; Mergui JL; Nieminen P; Prendiville W; Redman CW; Rieck GC; Quaas J; Petry KU
J Low Genit Tract Dis; 2014 Jan; 18(1):61-9. PubMed ID: 23774078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
